Compugen Ltd at Oppenheimer Healthcare Life Sciences Conference (Virtual) Transcript
Well, very good. Well, welcome back to Oppenheimer's 36th Annual Healthcare Life Sciences conference. I'm Leland Gershell. One of the analysts on the biotech research team here, and really thrilled to have Compugen as our next company that we'll be featuring.
Compugen is Public Ticker CGEN. We've been covering them with outperforming for some time. And we have President and CEO, Eran Ophir with us, who will be joining us for a discussion on the company's programs and opportunities. If you have any questions you'd like us to include, please submit those through the portal.
And with that, I just want to thank you, Eran, for joining us.
Thank you, Leland, for having us.
Questions & Answers
Good. So you have a few pipeline assets and programs, you've got the partnership, obviously with AstraZeneca, but internally your focus
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
